Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function

Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique

Clin Mol Hepatol. 2017;23(4):316-322. Published online August 22, 2017

DOI: https://doi.org/10.3350/cmh.2016.0087

View: 7155 Download: 187 Web of Science: 12 Crossref: 16

Predicting factors of present hepatitis C virus infection among patients positive for the hepatitis C virus antibody

Chi Hoon Lee, Hyun Phil Shin, Joung Il Lee, Kwang Ro Joo, Jae Myung Cha, Jung Won Jeon, Jun Uk Lim, Joon Ki Min, Dong Hee Kim, Sung Wook Kang, Hyun Jun Joung

Clin Mol Hepatol. 2013;19(4):376-381. Published online December 28, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.4.376

View: 7237 Download: 54 Crossref: 11

Case Report

A case of leukemoid reaction in a patient with sarcomatous hepatocellular carcinoma

Hyun Phil Shin, Jung Won Jeon, Jae Jun Park, Jae Myung Cha, Kwang Ro Joo, Joung Il Lee, Gou Young Kim, So Young Kang

Clin Mol Hepatol. 2011;17(3):226-228. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.226

View: 6991 Download: 61 Crossref: 7

1 |

Viewed By 5179	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5038	MAFLD: How is it different from NAFLD?
Viewed By 4992	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3675	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3632	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search